Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
368.92
+0.50 (0.14%)
Nov 4, 2024, 4:00 PM EST - Market closed
Bio-Rad Laboratories Employees
Bio-Rad Laboratories had 8,030 employees as of December 31, 2023. The number of employees decreased by 170 or -2.07% compared to the previous year.
Employees
8,030
Change (1Y)
-170
Growth (1Y)
-2.07%
Revenue / Employee
$321,321
Profits / Employee
-$96,973
Market Cap
10.33B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8,030 | -170 | -2.07% |
Dec 31, 2022 | 8,200 | 300 | 3.80% |
Dec 31, 2021 | 7,900 | -100 | -1.25% |
Dec 31, 2020 | 8,000 | -120 | -1.48% |
Dec 31, 2019 | 8,120 | -140 | -1.69% |
Dec 31, 2018 | 8,260 | 110 | 1.35% |
Dec 31, 2017 | 8,150 | -100 | -1.21% |
Dec 31, 2016 | 8,250 | 480 | 6.18% |
Dec 31, 2015 | 7,770 | 170 | 2.24% |
Dec 31, 2014 | 7,600 | -150 | -1.94% |
Dec 31, 2013 | 7,750 | 370 | 5.01% |
Dec 31, 2012 | 7,380 | 350 | 4.98% |
Dec 31, 2011 | 7,030 | 150 | 2.18% |
Dec 31, 2010 | 6,880 | 280 | 4.24% |
Dec 31, 2009 | 6,600 | 0 | - |
Dec 31, 2008 | 6,600 | 200 | 3.13% |
Dec 31, 2007 | 6,400 | 1,000 | 18.52% |
Dec 31, 2006 | 5,400 | 200 | 3.85% |
Dec 31, 2005 | 5,200 | 0 | - |
Dec 31, 2004 | 5,200 | 400 | 8.33% |
Dec 31, 2003 | 4,800 | 200 | 4.35% |
Dec 31, 2002 | 4,600 | 300 | 6.98% |
Dec 31, 2001 | 4,300 | 500 | 13.16% |
Dec 31, 2000 | 3,800 | -300 | -7.32% |
Dec 31, 1999 | 4,100 | 1,425 | 53.27% |
Dec 31, 1998 | 2,675 | 25 | 0.94% |
Dec 31, 1997 | 2,650 | 115 | 4.54% |
Dec 31, 1996 | 2,535 | 75 | 3.05% |
Dec 31, 1995 | 2,460 | 130 | 5.58% |
Dec 31, 1994 | 2,330 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Fresenius Medical Care AG | 119,845 |
Encompass Health | 37,761 |
Smith & Nephew | 19,081 |
Catalent | 17,800 |
AptarGroup | 13,800 |
Bio-Rad Laboratories | 8,030 |
Medpace Holdings | 5,900 |
Globus Medical | 5,000 |
BIO News
- 4 days ago - Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference - Business Wire
- 5 days ago - Bio-Rad Laboratories, Inc. (BIO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Bio-Rad Laboratories beats quarterly profit estimates on strong sales in diagnostics unit - Reuters
- 5 days ago - Bio-Rad Reports Third-Quarter 2024 Financial Results - Business Wire
- 21 days ago - Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024 - Business Wire
- 2 months ago - Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 - PRNewsWire
- 2 months ago - Bio-Rad's Management to Participate in Fireside Chat During Wells Fargo's 2024 Healthcare Conference - Business Wire
- 2 months ago - Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer - Business Wire